Identification of candidate gene variants of monogenic diabetes using targeted panel sequencing in early onset diabetes patients

• Published in: BMJ open diabetes research & care Vol. 9; no. 1; p. e002217
• Main Authors: Lee, Dong-Hwa, Kwak, Soo-Heon, Park, Hee Sue, Ku, Eu Jeong, Jeon, Hyun Jeong, Oh, Tae Keun
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group LTD 16.06.2021; BMJ Publishing Group
• Subjects: Diabetes; Family medical history; Genes; Genetics/Genomes/Proteomics/Metabolomics; Genomes; Genomics; Hospitals; Insulin; Medical diagnosis; Mutation; Pathogenesis; Patients; Peptides
• ISSN: 2052-4897; 2052-4897
• DOI: 10.1136/bmjdrc-2021-002217

IntroductionMonogenic diabetes is attributed to genetic variations in a single gene. Maturity-onset diabetes of the young (MODY) is the most common phenotype associated with monogenic diabetes, but is frequently misdiagnosed as either type 1 or type 2 diabetes. Increasing our basic understanding of genetic variations in MODY may help to improve the accuracy of providing the correct diagnosis and personalize subsequent treatment regimens in different racial populations. For this reason, this study was designed to identify nucleotide variants in early onset diabetes patients with clinically suspected MODY in a Korean population.Research design and methodsAmong 2908 Korean patients diagnosed with diabetes, we selected 40 patients who were diagnosed before 30 years old and were clinically suspected of MODY. Genetic testing was performed using a targeted gene sequencing panel that included 30 known monogenic diabetes genes. The pathogenicity of the identified variants was assessed according to the American College of Medical Genetics and Genomics and Association for Molecular Pathology (ACMG-AMP) guidelines.ResultsA total of six rare missense variants (p.Ala544Thr in HNF1A, p.Val601Ile and p.His103Tyr in ABCC8, p.Pro33Ala in PDX1, p.Gly18Glu in INS, and p.Arg164Gln in PAX4) in five distinct MODY genes were identified in five patients. In addition, a variant was identified in mitochondrial DNA at 3243A>G in one patient. The identified variants were either absent or detected at a rare frequency in the 1000 Genomes Project. These variants were classified as uncertain significance using the ACMG-AMP guidelines.ConclusionUsing a targeted gene sequencing panel, we identified seven variants in either MODY genes or mitochondrial DNA using a Korean patient population with early onset diabetes who were clinically suspected of MODY. This genetic approach provides the ability to compare distinct populations of racial and ethnic groups to determine whether specific gene is involved in their diagnosis of MODY.